Phosphoric Acid Monotetradecyl Ester
CAS 10054-29-2
Phosphoric Acid Monotetradecyl Ester (CAS 10054-29-2) is a pharmaceutical compound with 3 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 1047.3333333333333 nM | 3 | - |
| - | Ki | 646.5 nM | 2 | - |
| - | EC50 | 430 nM | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Phosphoric Acid Monotetradecyl Ester used for in pharmaceutical contexts?
Phosphoric Acid Monotetradecyl Ester (CAS 10054-29-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Phosphoric Acid Monotetradecyl Ester?
No adverse-event association or SIDER side-effect rows are rendered for Phosphoric Acid Monotetradecyl Ester in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Phosphoric Acid Monotetradecyl Ester also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for MYRISTYL PHOSPHATE with EU status "permitted".
What clinical phase is Phosphoric Acid Monotetradecyl Ester in?
No phase 1-4 clinical development badge is rendered for Phosphoric Acid Monotetradecyl Ester because the matched compound identifier rows do not contain a max-phase value.